Recent trials indicated effectiveness of open-source automated insulin delivery systems, inpatient insulin management based on continuous glucose monitoring (CGM), and CGM for certain patients with type 2 diabetes who are not taking insulin.
16 Sep 2022
One recent study compared sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists to each other, a meta-analysis tried to quantify their benefits compared to placebo, and a third study looked at their effects relative to insulin.
13 May 2022
Sports medicine experts updated their recommendations on exercise in type 2 diabetes, while a study found that physical activity was associated with lower dementia risk in patients with new type 2 diabetes, and another found that exercise might be more beneficial in the afternoon than the morning.
11 Mar 2022
The American Heart Association released a scientific statement on managing cardiovascular (CV) risk factors, while recent research focused on CV mortality in patients with diabetes and nonalcoholic fatty liver disease and CV outcomes in high-risk patients who take sodium-glucose cotransporter-2 inhibitors.
14 Jan 2022
A systematic review found that weight gain was associated with increased cardiovascular risk in type 2 diabetes patients but that the effects of intentional weight loss were unclear, while another analysis found that higher body mass index was mostly not associated with cancer mortality.
10 Dec 2021
Prediabetes and diabetes were associated with development of dementia in a South Korean study, and poorly controlled diabetes was tied to increased risk of incident cognitive impairment or progression to dementia in a Swedish study.
12 Nov 2021
A new study validated a score for predicting risk of heart failure in patients with type 2 diabetes, while another looked at historical trends in heart failure hospitalizations in U.S. diabetes patients.
11 Dec 2020
Recent articles looked at the risks of COVID-19 in patients with diabetes, optimal hospital treatment for those with both conditions, and new-onset diabetes in patients with COVID-19.
8 Jan 2021
Experts gave advice on which diabetes drugs should be stopped in patients with COVID-19, and studies highlighted associations between the two diseases.
8 May 2020
Recent studies of older patients with diabetes described the effectiveness of a lifestyle intervention, low use of continuous glucose monitoring, and high risk of falls with hypoglycemia.
12 Aug 2022